Crossmark

Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus

Crossref DOI link: https://doi.org/10.1007/s13760-018-0899-7

Published Online: 2018-03-03

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lambert, Catherine https://orcid.org/0000-0003-2222-0357
Dubois, Benedicte

Dive, Dominique

Lysandropoulos, Andreas

Selleslag, Dominik

Vanopdenbosch, Ludo

Van Pesch, Vincent

Vanwijmeersch, Bart

Janssens, Ann
License Information

Text and Data Mining valid from 2018-03-01
More Information

Article History

First Online: 3 March 2018